Status:
UNKNOWN
FOCUSau: A Dyadic Digital Health Intervention to Improve the Wellbeing of People With Advanced Cancer and Their Carers
Lead Sponsor:
University of Melbourne
Collaborating Sponsors:
St Vincent's Hospital Melbourne
University of Technology, Sydney
Conditions:
Advanced Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
FOCUS is a dyadic, psychoeducational intervention developed in the USA, shown to improve the wellbeing and quality of life (QoL) of patients with advanced cancer and their primary family carers. The i...
Detailed Description
STUDY SETTING: The patient-carer dyads will be recruited via two methods: (1) referral from hospitals or (2) self-referral. For method one, approximately six hospitals and/or cancer centres (metropol...
Eligibility Criteria
Inclusion
- Patient
- Diagnosis of advanced cancer
- Over 18 years of age
- Able to comprehend written or spoken English
- No visual, hearing, and/or cognitive impairment that would preclude participation
- Able to commit to research participation requirements (including data collection and completion of the FOCUSau intervention if randomised to that group)
- Able to access the internet (on desktop computer, laptop computer or tablet device)
- Able to identify a primary support person/carer, who is an unpaid individual (not necessarily a partner or family member) who is providing physical, social or emotional support.
- Patient
Exclusion
- \- Involvement in an advanced cancer non-drug trial that focuses on improving QoL
- Family carer Inclusion Criteria:
- Identified by the patient as their primary support person who is related to them biologically, legally or emotionally, and is willing to accept this support role
- Aged over 18 years
- No visual, hearing, and/or cognitive impairment that would preclude participation
- Able to commit to research participation requirements
- Able to access the internet
- Dyad Inclusion Criteria:
- \- Capacity to effectively utilise the internet (as determined through a short practical online exercise as part of the screening and consent process).
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
433 Patients enrolled
Trial Details
Trial ID
NCT06082128
Start Date
December 1 2023
End Date
August 1 2025
Last Update
October 13 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Calvary Healthcare Kogarah
Kogarah, New South Wales, Australia, 2217
2
Mater Health Service
Kangaroo Point, Queensland, Australia, 4169
3
Northern Adelaide Palliative Service
Modbury, South Australia, Australia, 5092
4
Barwoon Health Mckellar Centre
Geelong, Victoria, Australia, 3215